These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37953242)

  • 1. Tumor treating fields: narrative review of a promising treatment modality for cancer.
    Kutuk T; Atak E; La Rosa A; Kotecha R; Mehta MP; Chuong MD
    Chin Clin Oncol; 2023 Dec; 12(6):64. PubMed ID: 37953242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor treating fields: a comprehensive overview of the underlying molecular mechanism.
    Hong P; Kudulaiti N; Wu S; Nie J; Zhuang D
    Expert Rev Mol Diagn; 2022 Jan; 22(1):19-28. PubMed ID: 34883030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice.
    Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M
    J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of the preclinical evaluation of alternating electric fields as a form of cancer therapy.
    Pohling C; Nguyen H; Chang E; Schubert KE; Nie Y; Bashkirov V; Yamamoto V; Zeng Y; Stupp R; Schulte RW; Patel CB
    Bioelectrochemistry; 2023 Feb; 149():108287. PubMed ID: 36306728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Evolving Role of Tumor Treating Fields in Managing Glioblastoma: Guide for Oncologists.
    Burri SH; Gondi V; Brown PD; Mehta MP
    Am J Clin Oncol; 2018 Feb; 41(2):191-196. PubMed ID: 28832384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour treating fields therapy for glioblastoma: current advances and future directions.
    Rominiyi O; Vanderlinden A; Clenton SJ; Bridgewater C; Al-Tamimi Y; Collis SJ
    Br J Cancer; 2021 Feb; 124(4):697-709. PubMed ID: 33144698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternating electric fields (tumor-treating fields therapy) can improve chemotherapy treatment efficacy in non-small cell lung cancer both in vitro and in vivo.
    Giladi M; Weinberg U; Schneiderman RS; Porat Y; Munster M; Voloshin T; Blatt R; Cahal S; Itzhaki A; Onn A; Kirson ED; Palti Y
    Semin Oncol; 2014 Oct; 41 Suppl 6():S35-41. PubMed ID: 25213867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor Treating Fields in the Management of Patients with Malignant Gliomas.
    Ghiaseddin AP; Shin D; Melnick K; Tran DD
    Curr Treat Options Oncol; 2020 Jul; 21(9):76. PubMed ID: 32734509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-Treating Fields: A fourth modality in cancer treatment, new practice updates.
    Arvind R; Chandana SR; Borad MJ; Pennington D; Mody K; Babiker H
    Crit Rev Oncol Hematol; 2021 Dec; 168():103535. PubMed ID: 34808377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the Role of Tumor-treating Fields in Newly Diagnosed Glioblastoma?
    Ornelas AS; Porter AB; Sharma A; Knox MG; Marks LA; Wingerchuk DM; O'Carroll CB
    Neurologist; 2019 Mar; 24(2):71-73. PubMed ID: 30817495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTEN mutations predict benefit from tumor treating fields (TTFields) therapy in patients with recurrent glioblastoma.
    Dono A; Mitra S; Shah M; Takayasu T; Zhu JJ; Tandon N; Patel CB; Esquenazi Y; Ballester LY
    J Neurooncol; 2021 May; 153(1):153-160. PubMed ID: 33881725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-treating fields plus chemotherapy versus chemotherapy alone for glioblastoma at first recurrence: a post hoc analysis of the EF-14 trial.
    Kesari S; Ram Z;
    CNS Oncol; 2017 Jul; 6(3):185-193. PubMed ID: 28399638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of tumor treating fields for malignant brain tumors.
    Zhou Y; Xing X; Zhou J; Jiang H; Cen P; Jin C; Zhong Y; Zhou R; Wang J; Tian M; Zhang H
    Cancer Rep (Hoboken); 2023 May; 6(5):e1813. PubMed ID: 36987739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of tumor treating fields (TTFields): advancements in clinical applications and mechanistic insights.
    Li X; Liu K; Xing L; Rubinsky B
    Radiol Oncol; 2023 Sep; 57(3):279-291. PubMed ID: 37665740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies.
    Wang Y; Pandey M; Ballo MT
    Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Tumor-Treating Fields (TTFields): Clinical Implications Inferred From Computational Modeling.
    Wenger C; Miranda PC; Salvador R; Thielscher A; Bomzon Z; Giladi M; Mrugala MM; Korshoej AR
    IEEE Rev Biomed Eng; 2018; 11():195-207. PubMed ID: 29993870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial.
    Kim CY; Paek SH; Nam DH; Chang JH; Hong YK; Kim JH; Kim OL; Kim SH
    J Neurooncol; 2020 Feb; 146(3):399-406. PubMed ID: 32020470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global post‑marketing safety surveillance of Tumor Treating Fields (TTFields) therapy in over 25,000 patients with CNS malignancies treated between 2011-2022.
    Mrugala MM; Shi W; Iwomoto F; Lukas RV; Palmer JD; Suh JH; Glas M
    J Neurooncol; 2024 Aug; 169(1):25-38. PubMed ID: 38949692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer.
    Pless M; Droege C; von Moos R; Salzberg M; Betticher D
    Lung Cancer; 2013 Sep; 81(3):445-450. PubMed ID: 23891283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma.
    Riley MM; San P; Lok E; Swanson KD; Wong ET
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.